These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1980236)

  • 21. Regulation of lipoprotein metabolism by adrenergic mechanisms.
    Dzau VJ; Sacks FM
    J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S2-6. PubMed ID: 2447436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha 1-blockers, their antihypertensive efficacy and effects on lipids and lipoprotein.
    Kincaid-Smith P
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():75-83. PubMed ID: 2575178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.
    Ames RP
    Drugs; 1986 Oct; 32(4):335-57. PubMed ID: 2877846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P; Ferrier C; Saxenhofer H; Uehlinger DE; Trost BN
    Drugs; 1988; 35 Suppl 6():118-34. PubMed ID: 3042351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of antihypertensives on plasma lipids and lipoprotein metabolism.
    Krone W; Nägele H
    Am Heart J; 1988 Dec; 116(6 Pt 2):1729-34. PubMed ID: 3059788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance.
    Cubeddu LX
    Am Heart J; 1988 Jul; 116(1 Pt 1):133-62. PubMed ID: 2899387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of liver lipase. II. Involvement of the alpha 1-receptor.
    Schoonderwoerd K; Hülsmann WC; Jansen H
    Biochim Biophys Acta; 1984 Oct; 795(3):481-6. PubMed ID: 6148107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of alpha- and beta-blocker therapy on blood lipids: European experience.
    Leren P
    Am J Med; 1984 Feb; 76(2A):67-71. PubMed ID: 6142644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sympathetic nervous system and hypertension. Therapeutic perspectives.
    Weber MA
    Am J Hypertens; 1989 Mar; 2(3 Pt 2):147S-152S. PubMed ID: 2564278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terazosin: a new antihypertensive agent with favorable effects on lipids.
    Luther RR
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):313-9. PubMed ID: 2570758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S; Simons LA; Hickie JB; Chang S
    Artery; 1990; 17(2):60-70. PubMed ID: 1968740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
    Titmarsh S; Monk JP
    Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of doxazosin and other antihypertensives on serum lipid levels and lipoprotein lipase in the C57BR/cdJ mouse.
    Krupp MN; Hoover KW; Valentine JJ
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S11-8; discussion S18-9. PubMed ID: 2471010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of alpha blockade for blood pressure control.
    Davey M
    Am J Cardiol; 1987 May; 59(14):18G-28G. PubMed ID: 2884849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects.
    Westheim A; Daae LN; Kierulf P; Brusletto B; Holme I; Syvertsen JO
    J Hypertens Suppl; 1990 Sep; 8(5):S41-6. PubMed ID: 1981076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacotherapeutics of doxazosin.
    Taylor SH
    Am J Med; 1989 Aug; 87(2A):2S-11S. PubMed ID: 2569822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of adrenoceptor-blocking drugs on plasma lipoprotein concentrations.
    Miller NE
    Am J Cardiol; 1987 Sep; 60(9):17E-23E. PubMed ID: 2889350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of diuretics and adrenergic-blocking agents on plasma lipids.
    Rohlfing JJ; Brunzell JD
    West J Med; 1986 Aug; 145(2):210-8. PubMed ID: 2876554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of beta-blockers on plasma lipids during antihypertensive therapy.
    Lehtonen A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S110-4. PubMed ID: 2409357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenergic mechanisms in control of plasma lipid concentrations.
    Day JL; Metcalfe J; Simpson CN
    Br Med J (Clin Res Ed); 1982 Apr; 284(6323):1145-8. PubMed ID: 6122483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.